Table 3.
Univariate analyses of associated with chemotherapeutic sensitive disease.
| Variables | chemotherapeutic sensitive(n=43) | chemotherapeutic resistant or refractory (n=38) | Univariate P value | Multivariate P value | Multivariate OR(95%CI) | |
|---|---|---|---|---|---|---|
| Age(years) | 0.873 | |||||
| ≤55 | 23 | 21 | ||||
| >55 | 20 | 17 | ||||
| FIGO Stage | 0.249 | |||||
| III | 38 | 30 | ||||
| IV | 5 | 8 | ||||
| Histology | 0.023 | 0.092 | 3.046(0.834-11.122) | |||
| Serous | 39 | 27 | ||||
| None serous | 4 | 11 | ||||
| CA125U/ml≤1800U/ml presentation | Yes | 17 | 22 | 0.099 | ||
| No | 26 | 16 | ||||
| CA125U/ml≤850U/ml after the 1st NAC* | Yes | 25 | 16 | 0.145 | ||
| No | 15 | 19 | ||||
| Reduction CA125U/ml>30% after the 1st NAC* | Yes | 20 | 19 | 0.711 | ||
| No | 20 | 16 | ||||
| CA125≤200U/ml preoperatively | Yes | 21 | 10 | 0.037 | 0.142 | 2.086(0.781-5.570) |
| No | 22 | 28 | ||||
| Reduction CA125U/ml>80% presentation to preop | Yes | 22 | 13 | 0.124 | ||
| No | 21 | 25 |
*Some patients did not measure.